| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/16/2008 | US7465435 Delivery of beta-blockers through an inhalation route |
| 12/16/2008 | US7465293 Syringe for inducing therapeutically-effective proteins |
| 12/16/2008 | CA2398887C 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 12/16/2008 | CA2328411C Glucocorticoid receptor antagonists for the treatment of dementia |
| 12/16/2008 | CA2295519C A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 12/16/2008 | CA2294913C Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative |
| 12/16/2008 | CA2285817C Novel basic derivatives of benz[e]isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-ht3-antagonistic activity, their preparation and their therapeutic use |
| 12/11/2008 | WO2008151170A2 Process for the synthesis of ramelteon and its intermediates |
| 12/11/2008 | WO2008150525A1 Anti-notch1 nrr antibodies and methods using same |
| 12/11/2008 | WO2008150467A1 Screening assays for inhibitors of beta amyloid peptide ion channel formation |
| 12/11/2008 | WO2008150302A1 Treatment of neurofibromatosis with radicicol and its derivatives |
| 12/11/2008 | WO2008150001A1 Adipocluster |
| 12/11/2008 | WO2008149971A1 Therapeutic or prophylactic agent for cerebral aneurysm |
| 12/11/2008 | WO2008149838A1 Novel fractionation product of royal jelly, method for production of the same, and use of the same |
| 12/11/2008 | WO2008149521A1 Therapeutic agent for cancer, and method for treatment of cancer |
| 12/11/2008 | WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | WO2008148303A1 A composition for treating vegetative dystonine syndrome and pharmaceutical preparation and application thereof |
| 12/11/2008 | WO2008098077A3 Substituted alkine derivatives as anti-cancer agents |
| 12/11/2008 | WO2008045461A3 Transdermal diethylstilbestrol for treating prostate cancer |
| 12/11/2008 | US20080306275 Novel heteroaryl derivative |
| 12/11/2008 | US20080306158 Methods to Prevent Cytotoxicity Using N-Acetyl-Cysteine |
| 12/11/2008 | US20080306157 Therapeutic intervention to MIMIC the effect of caloric restriction |
| 12/11/2008 | US20080306149 Use for a Composition Comprising Chloroprocaine Hcl, a New Composition Comprising Chloroprocaine Hcl and a Method for Its Manufacture |
| 12/11/2008 | US20080306109 Indolizine Derivatives as Ligands of the Crth2 Receptor |
| 12/11/2008 | US20080306106 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/11/2008 | US20080306104 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 12/11/2008 | US20080306085 Non-imidazole aryloxyalkylamines |
| 12/11/2008 | US20080306065 Metalloproteinase Inhibitors |
| 12/11/2008 | US20080306057 P13K Inhibitors for the Treatment of Endometriosis |
| 12/11/2008 | US20080306016 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications |
| 12/11/2008 | US20080306014 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial |
| 12/11/2008 | US20080306011 Method of Controlling the Proliferation of Vascular Endothelial Cells and Inhibiting Lumen Formation |
| 12/11/2008 | US20080306009 Tetrapeptide Leu-Ala-Gly-Val derived from human chorionic gonadotropin; nitric oxide biosynthesis modulator |
| 12/11/2008 | US20080306005 Treatment of bone disorders with skeletal anabolic drugs |
| 12/11/2008 | US20080306004 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 12/11/2008 | US20080305998 appetite stimulants, antiobesity drugs, prolactin production inhibitors; drug screening; G-protein coupled (GPR) |
| 12/11/2008 | US20080305988 V-Like Domain Binding Molecules |
| 12/11/2008 | US20080305543 RNA interference pathway genes as tools for targeted genetic interference |
| 12/11/2008 | US20080305193 Cosmetic compositions |
| 12/11/2008 | US20080305167 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080305164 Crystalline composition containing escitalopram |
| 12/11/2008 | US20080305159 Ibuprofen-Hydrocodone-Antihistamine Composition |
| 12/11/2008 | US20080305145 Process for demineralization of bone matrix with preservation of natural growth factors |
| 12/11/2008 | US20080305125 Mutant Forms Of EtxB and CtxB And Their Use As Carriers |
| 12/11/2008 | US20080305113 Pharmaceutical Composition for Preventing or Treating Chronic Graft-Versus-Disease Comprising Anti-CD137 Monoclonal Antibody |
| 12/11/2008 | US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof |
| 12/11/2008 | US20080305109 Method of passive immunization |
| 12/11/2008 | US20080305108 Peptides of Il1 Beta and Tnf Alpha and Method Treatment |
| 12/11/2008 | US20080305098 Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor |
| 12/11/2008 | US20080305090 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times |
| 12/11/2008 | US20080305088 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 12/11/2008 | US20080305068 Cosmetic compositions having improved transfer resistance |
| 12/11/2008 | US20080305046 Molecular imaging methods for diagnosis and evaluation of ocular and systemic diseases |
| 12/11/2008 | US20080302385 Cosmetic tool having antibacterial property and method for producing the same |
| 12/11/2008 | CA2727100A1 Treatment of neurofibromatosis with radicicol and its derivatives |
| 12/11/2008 | CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | CA2689242A1 Agent and method for treatment of cancer |
| 12/11/2008 | CA2687866A1 Anti-notch1 nrr antibodies and methods using same |
| 12/10/2008 | EP2000536A2 Tat-derived transport polypeptides |
| 12/10/2008 | EP2000478A1 Biologically active peptide and agent containing the same |
| 12/10/2008 | EP2000473A2 Trehalose compound and pharmaceutical comprising the compound |
| 12/10/2008 | EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications |
| 12/10/2008 | EP2000461A1 Crystalline forms of atorvastatin |
| 12/10/2008 | EP2000150A2 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle |
| 12/10/2008 | EP2000145A2 Ameliorating agent for metabolic syndrome |
| 12/10/2008 | EP2000137A2 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
| 12/10/2008 | EP2000136A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 12/10/2008 | EP1998767A2 Method for promoting composite tissue regeneration and uses thereof |
| 12/10/2008 | EP1998760A2 Non peptidic molecules for detecting and treating tumors |
| 12/10/2008 | EP1541163B1 Hair growth stimulants for oral use |
| 12/10/2008 | EP1511730B1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 12/10/2008 | EP1492501B1 Methods of using lamellar bodies for therapeutic purposes |
| 12/10/2008 | EP1475382B1 Compounds as semaphorin inhibitors |
| 12/10/2008 | EP1396487B1 Phenylpyridine carbonyl piperazine derivative |
| 12/10/2008 | EP1391199B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 12/10/2008 | EP1274450B1 Medical uses of agonsist and antagonists of IL-174 |
| 12/10/2008 | EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/10/2008 | EP1066056B2 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
| 12/10/2008 | EP1002069B1 Peptides containing the motif igd and their use as cell migration modulators |
| 12/10/2008 | CN101321535A Heteroaromatic sulfonamide prodrugs |
| 12/10/2008 | CN101318005A Method for preparing capsule for activating Yang and removing obstruction |
| 12/10/2008 | CN101317993A Externally used plaster medicine for children's urorrhea and frequent micturition |
| 12/10/2008 | CN101317983A Method for preparing capsule for nourishing Yin and suppressing Yang, discharging fire and pacifying the mind |
| 12/10/2008 | CN101317937A Method for preparing capsule for reliving Qi and reliving upset |
| 12/10/2008 | CN101317932A Externally applied traditional Chinese medicine preparation for channels and collaterals persuasion |
| 12/10/2008 | CN101317915A Decoction medicament for treating deficiency of both qi and yin type kakidrosis |
| 12/10/2008 | CN101317848A Eplerenone crystalline form |
| 12/10/2008 | CN100441594C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 12/10/2008 | CN100441574C Tricyclic compounds, their production and use |
| 12/10/2008 | CN100441556C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 12/10/2008 | CN100441176C Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 12/10/2008 | CN100441170C Astragalus root extract chewing tablet and preparation method of astragalus root extract |
| 12/10/2008 | CN100441103C Coated chewing gum |
| 12/09/2008 | US7462696 Human antibodies that have MN binding and cell adhesion-neutralizing activity |
| 12/09/2008 | US7462642 Anti-cancer combinations |
| 12/09/2008 | US7462641 (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof |
| 12/09/2008 | US7462636 Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors |
| 12/09/2008 | US7462635 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia |
| 12/09/2008 | US7462630 Diarylalkene derivatives and novel diarylalkane derivatives |